164221-12-9

Basic information

• Product Name: (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol
• Synonyms: (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol
• CAS NO: 164221-12-9
• Molecular Weight: 288.473
• Mol File: 164221-12-9.mol
• Article Data: 16

Chemical Properties

• CAS DataBase Reference: (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol(CAS DataBase Reference)
• NIST Chemistry Reference: (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol(164221-12-9)
• EPA Substance Registry System: (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol(164221-12-9)

Safety Data

• Hazardous Substances Data: 164221-12-9(Hazardous Substances Data)

Usage

Description

(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol, commonly known as icosa-5,8,11,14,17-pentaen-1-ol, is a long-chain unsaturated alcohol with 20 carbon atoms and 5 double bonds arranged in a zig-zag configuration. It belongs to the family of long-chain unsaturated alcohols and possesses unique properties due to its multiple double bonds in the carbon chain.

Uses

Used in Industrial Applications:
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol is used as a raw material in the production of various industrial products, such as surfactants, lubricants, and plasticizers. Its unique properties make it suitable for various chemical and industrial processes.
Used in Pharmaceutical Industry:
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol has potential applications in the pharmaceutical industry, where it can be utilized for the development of new drugs or as an intermediate in the synthesis of pharmaceutical compounds.
Used in Cosmetic Industry:
(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-ol can also be used in the cosmetic industry, where it may serve as an ingredient in the formulation of skincare products, hair care products, or other cosmetic formulations due to its unique properties.

Upstream product

• 10417-94-4 all cis-5,8,11,14,17-eicosapentaenoic acid 
• 86227-47-6 eicosapentaenoic acid ethyl ester 
• 2566-90-7 all-cis-4,7,10,13,16,19-docosahexaenoic acid methyl ester 
• 2734-47-6 (5Z,8Z,11Z,14Z,17Z)-5,8,11,14,17-icosapentaenoic acid methyl ester 

Downstream Products

• 1192949-29-3 (all-Z)-5,8,11,14,17-eicosapentaen-1-yl di-methyl-phosphonate 
• 119818-40-5 (7Z,10Z,13Z,16Z,19Z)-ethyl docosa-7,10,13,16,19-pentaenoate 
• 875288-80-5 methyl (2E,7Z,10Z,13Z,16Z,19Z)-docosa-2,7,10,13,16,19-hexaenoate 
• 1253909-49-7 (4S,5R)-3-((R)-2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoyl)-4-methyl-5-phenyloxazolidin-2-one 
• 1253909-48-6 (4S,5R)-3-((S)-2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenyloxy)butanoyl)-4-methyl-5-phenyloxazolidin-2-one 
• 1316749-16-2 2-((2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanoyl)oxy)benzoic acid 
• 1316749-15-1 tert-butyl 2-((2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanoyl)oxy)benzoate 
• 1316749-50-4 2-hydroxy-5-(3-(2-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanamido)ethyl)ureido)benzoic acid 
• 1316749-49-1 methyl 2-hydroxy-5-(3-(2-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanamido)ethyl)ureido)benzoate 
• 1316749-43-5 2-hydroxy-5-(((2-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanamido)ethoxy)carbonyl)amino)benzoic acid 
• 1316749-41-3 methyl 2-hydroxy-5-(((2-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanamido)ethoxy)carbonyl)amino)benzoate 
• 1316749-40-2 2-hydroxy-5-((2S)-2-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanamido)-4-methylpentanamido)benzoic acid 
• 1316749-37-7 methyl 2-hydroxy-5-((2S)-2-(2-((5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaen-1-yloxy)butanamido)-4-methylpentanamido)benzoate 
• 1316749-23-1 2-hydroxy-N-(2-(2-((5Z,8Z_,11Z_,14Z,17Z)-icosa-5_,8_,11,14,17-pentaen-1-yloxy)butanamido)ethyl)benzamide 

Relevant articles and documents

A New Lipobetaine from the Red Alga Neodilsea yendoana

A new isosanoid lipobetaine has been isolated from a red alga and its structure has been determined to be (2S)-2--(8Z,11Z,14Z)-8,11,14-icosatrienoylamino>-5-trimethylammoniopentanoate, mainly on the basis of NMR spectral and chemical means.

NSAID derivatives of omega-3 polyunsaturated acids as gamma secretase modulators

The present invention relates to the NSAID derivatives of omega-3 fatty acids as gamma secretase modulators and their use in treating Alzheimer's disease, hypertriglyceridemia, and cardiovascular disease by reducing triglycerides, and for use as anti-inflammatory agents.

METHOD FOR CHEMICAL CONVERSION OF UNSATURATED FATTY ACID BY CARBON CHAIN EXTENSION REACTION

The present invention relates to a method for the chemical conversion of an unsaturated fatty acid, particularly a carbon chain extension reaction. According to the present invention, a method for extending the length of a carbon chain in an unsaturated fatty acid by two carbon atoms is provided, said method comprising a step of heating a malonic acid ester derivative of an unsaturated fatty acid to reflux in a lower fatty acid solution in the presence of an antioxidative agent. It is preferred that the unsaturated fatty acid is an unsaturated fatty acid having 16 to 24 carbon atoms. It is preferred that the unsaturated fatty acid is selected from the group consisting of linoleic acid, linolenic acid, arachidonic acid, stearidonic acid, icosatetraenoic acid, icosapentaenoic acid, tetracosahexaenoic acid and docosahexaenoic acid. According to the method of the present invention, a carbon chain extension reaction can be completed within a shorter time.